Corticosteroids for acute bacterial meningitis

MC Brouwer, P McIntyre, J de Gans… - Cochrane database …, 2010 - cochranelibrary.com
Background In experimental studies, the outcome of bacterial meningitis has been related to
the severity of inflammation in the subarachnoid space. Corticosteroids reduce this …

Pathogenesis of bacterial meningitis

SL Leib, MG Täuber - Infectious disease clinics of North America, 1999 - Elsevier
Bacterial meningitis is the most common serious infection of the central nervous system.
Infection of the subarachnoid space leads to cerebrospinal fluid (CSF) inflammation …

Practice guidelines for the management of bacterial meningitis

AR Tunkel, BJ Hartman, SL Kaplan… - Clinical infectious …, 2004 - academic.oup.com
Objectives The objective of these practice guidelines is to provide clinicians with
recommendations for the diagnosis and treatment of bacterial meningitis. Patients with …

Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data

D Van de Beek, JJ Farrar, J de Gans, NTH Mai… - The Lancet …, 2010 - thelancet.com
Background Dexamethasone improves outcome for some patients with bacterial meningitis,
but not others. We aimed to identify which patients are most likely to benefit from …

Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988

PB Mclntyre, CS Berkey, SM King, UB Schaad, T Kilpi… - Jama, 1997 - jamanetwork.com
Objective.—To evaluate the effectiveness of dexamethasone in bacterial meningitis in the
subcategories of causative organism and timing and nature of antibiotic therapy. Data …

Twelve year outcomes following bacterial meningitis: further evidence for persisting effects

K Grimwood, P Anderson, V Anderson, L Tan… - Archives of disease in …, 2000 - adc.bmj.com
AIM To determine whether intellectual and cognitive impairments observed seven years
following early childhood bacterial meningitis persist into adolescence. METHODS Blinded …

Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological …

D Leppert, SL Leib, C Grygar, KM Miller… - Clinical Infectious …, 2000 - academic.oup.com
To evaluate the spectrum and regulation of matrix metalloproteinases (MMPs) in bacterial
meningitis (BM), concentrations of MMP-2, MMP-3, MMP-8, and MMP-9 and endogenous …

Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial

EM Molyneux, AL Walsh, H Forsyth, M Tembo… - The Lancet, 2002 - thelancet.com
Background Steroids are used as adjuvant treatment in childhood pyogenic meningitis to
attenuate host inflammatory responses to bacterial invasion. We aimed to assess the …

Use of corticosteroids in treating infectious diseases

S McGee, J Hirschmann - Archives of internal medicine, 2008 - jamanetwork.com
Clinicians have generally avoided prescribing corticosteroids for active infection because of
their known immunosuppressive effects and concern about long-term complications. We …

5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study

E Molyneux, SQ Nizami, S Saha, KT Huu, M Azam… - The Lancet, 2011 - thelancet.com
Background Bacterial meningitis is an important cause of morbidity and mortality in
developing countries, but the duration of treatment is not well established. We aimed to …